IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ:IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference.
Related news for (IRMD)
- IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
- IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
- IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
- IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
- IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference